Literature DB >> 29401384

Mechanistic Studies of the Inhibition of Insulin Fibril Formation by Rosmarinic Acid.

Qiuchen Zheng1, Noel D Lazo1.   

Abstract

The self-assembly of insulin to form amyloid fibrils has been widely studied because it is a significant problem in the medical management of diabetes and is an important model system for the investigation of amyloid formation and its inhibition. A few inhibitors of insulin fibrillation have been identified with potencies that could be higher. Knowledge of how these work at the molecular level is not known but important for the development of more potent inhibitors. Here we show that rosmarinic acid completely inhibits amyloid formation by dimeric insulin at pH 2 and 60 °C. In contrast to other polyphenols, rosmarinic acid is soluble in water and does not degrade at elevated temperatures, and thus we were able to decipher the mechanism of inhibition by a combination of solution-state 1H NMR spectroscopy and molecular docking. On the basis of 1H chemical shift perturbations, intermolecular nuclear Overhauser effect enhancements between rosmarinic acid and specific residues of insulin, and slowed dynamics of rosmarinic acid in the presence of insulin, we show that rosmarinic acid binds to a pocket found on the surface of each insulin monomer. This results in the formation of a mixed tetramolecular aromatic network on the surface of insulin dimer, resulting in increased resistance of the amyloidogenic protein to thermal unfolding. This finding opens new avenues for the design of potent inhibitors of amyloid formation and provides strong experimental evidence for the role of surface aromatic clusters in increasing the thermal stability of proteins.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29401384     DOI: 10.1021/acs.jpcb.8b00689

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  11 in total

Review 1.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 2.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

3.  Inhibitory effect of coumarin and its analogs on insulin fibrillation /cytotoxicity is depend on oligomerization states of the protein.

Authors:  Mohsen Akbarian; Ehsan Rezaie; Fatemeh Farjadian; Zahra Bazyar; Mona Hosseini-Sarvari; Ehsan Malek Ara; Seyed Ali Mirhosseini; Jafar Amani
Journal:  RSC Adv       Date:  2020-10-16       Impact factor: 4.036

4.  Nanomedical Relevance of the Intermolecular Interaction Dynamics-Examples from Lysozymes and Insulins.

Authors:  Ruiyan Zhang; Ning Zhang; Marzieh Mohri; Lisha Wu; Thomas Eckert; Vadim B Krylov; Andrea Antosova; Slavomira Ponikova; Zuzana Bednarikova; Philipp Markart; Andreas Günther; Bengt Norden; Martin Billeter; Roland Schauer; Axel J Scheidig; Bhisma N Ratha; Anirban Bhunia; Karsten Hesse; Mushira Abdelaziz Enani; Jürgen Steinmeyer; Athanasios K Petridis; Tibor Kozar; Zuzana Gazova; Nikolay E Nifantiev; Hans-Christian Siebert
Journal:  ACS Omega       Date:  2019-02-27

Review 5.  The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Authors:  Ancuta-Veronica Lupaescu; Monica Iavorschi; Mihai Covasa
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

6.  Molecular docking analysis and anti-hyperglycaemic activity of Synacinn™ in streptozotocin-induced rats.

Authors:  Nur Syukriah Ab Rahman; Fadzilah Adibah Abdul Majid; Mohd Effendy Abd Wahid; Hassan Fahmi Ismail; Fatahiya Mohamed Tap; Ain Nabihah Zainudin; Siti Nurazwa Zainol; Muzaida Aminah Mohammad
Journal:  RSC Adv       Date:  2020-09-18       Impact factor: 4.036

7.  Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping.

Authors:  Meghomukta Mukherjee; Debajyoti Das; Jit Sarkar; Nilanjan Banerjee; Jagannath Jana; Jyotsna Bhat; Jithender Reddy G; Jagadeesh Bharatam; Samit Chattopadhyay; Subhrangsu Chatterjee; Partha Chakrabarti
Journal:  iScience       Date:  2021-05-21

8.  Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.

Authors:  Valerie A Ivancic; Claire A Krasinski; Qiuchen Zheng; Rebecca J Meservier; Donald E Spratt; Noel D Lazo
Journal:  Biosci Rep       Date:  2018-11-07       Impact factor: 3.840

9.  Molecular Dynamics Investigations Suggest a Non-specific Recognition Strategy of 14-3-3σ Protein by Tweezer: Implication for the Inhibition Mechanism.

Authors:  Mingsong Shi; Dingguo Xu
Journal:  Front Chem       Date:  2019-04-17       Impact factor: 5.221

Review 10.  Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease.

Authors:  Ana F Raimundo; Sofia Ferreira; Ivo C Martins; Regina Menezes
Journal:  Front Mol Neurosci       Date:  2020-03-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.